Introduction
Hypoxia is a well-known cause of cell death (Harris, 2002; Weinmann et al., 2004) . Complete abrogation of oxygen supply and depletion of ATP normally results in cellular necrosis. In the penumbra of ischemic lesions or in malignant tumors, cells are exposed not only to anoxia, but rather to reduced levels of tissue oxygenation resulting in moderate to severe cellular hypoxia. In this context, it has been demonstrated that hypoxia can induce apoptotic as well as necrotic forms of cellular death (Shimizu et al., 1995 (Shimizu et al., , 1996 .
Generally, the induction and execution of apoptosis is controlled by proapoptotic cysteine proteases, so-called caspases, that are synthesized as inactive precursors and need to be activated by proteolytic processing (Fischer et al., 2003) . Caspase activation can be triggered by two distinct, but interrelated pathways, the extrinsic (death receptor-mediated) and the intrinsic pathway (mitochondrial apoptosis pathway). Both pathways are differentially involved in the cellular response to diverse apoptotic stimuli (Belka et al., 1999b Engels et al., 2000; Newton and Strasser, 2000; Rudner et al., 2001b; Wieder et al., 2001) .
Ligand-mediated multimerization of death receptors like CD95, TNFa-or TRAIL receptors initiates apoptosis via recruitment of the FADD adapter molecule and procaspase-8 to the receptor complex which in turn triggers the autoproteolytic activation of caspase-8 (Chinnaiyan et al., 1995; Muzio et al., 1996 Muzio et al., , 1998 Medema et al., 1997; Kischkel et al., 2000 Kischkel et al., , 2001 . Although caspase-8 is a key player for the extrinsic pathway of apoptosis, the highly related caspase-10 may act as surrogate for caspase-8 in some cell systems (Kischkel et al., 2001) . Caspase-8 activates downstream effector caspases including caspase-3, -6 or -7, which degrade a broad range of cellular proteins, thereby executing the final steps of apoptosis (for a review, see Igney and Krammer, 2002; Fischer et al., 2003) .
The key event during the activation of the intrinsic pathway of apoptosis is characterized by mitochondrial damage in combination with the release of cytochrome c into the cytosol (Kluck et al., 1997; Li et al., 1997; Soengas et al., 1999; Renz et al., 2001) . The mitochondrial pathway is triggered by diverse proapoptotic cellular stresses including anticancer drugs, ceramide, staurosporine, UV-and g-irradiation (Engels et al., 2000; Stepczynska et al., 2001; Qin et al., 2002; von Haefen et al., 2002; Belka et al., 2003a, b; Jendrossek et al., 2003b) .
In the presence of dATP/ATP, cytochrome c binds to, and triggers the oligomerization of APAF-1. The resulting 'apoptosome' recruits and activates caspase-9, which in turn cleaves downstream effector caspases and apoptotic cell death is finalized (Li et al., 1997; Soengas et al., 1999) . In this context, the activation of caspase-8 constitutes only a secondary effect Engels et al., 2000; Wieder et al., 2001) .
Since the antiapoptotic members of the Bcl-2 protein family, for example, Bcl-2 and Bcl-xL were shown to inhibit key steps of the mitochondrial signaling pathway, radiation-and drug-induced apoptosis are almost completely abrogated by overexpression of Bcl-2 (Engels et al., 2000; Rudner et al., 2001a Rudner et al., , b, 2002 Belka and Budach, 2002) .
However, the extrinsic and intrinsic signaling pathways are interconnected at several levels. As stated above, caspase-8 for example is activated secondarily in response to mitochondrial death stimuli. Similarly, the death receptor-mediated apoptosis pathway triggers a mitochondrial amplification loop (Scaffidi et al., 1998; Belka et al., 2000) . In this regard, active caspase-8 induces the activation of proapoptotic BID, which in turn leads to the release of cytochrome c from the mitochondria and subsequent activation of caspase-9 . This mitochondrial amplification loop guarantees proper execution of death-receptor-mediated apoptosis in cells with low initial activation of caspase-8 (Scaffidi et al., 1998; Belka et al., 2000; Igney and Krammer, 2002) .
The contribution of both apoptotic signaling cascades and their relative significance to hypoxia-induced apoptosis is not fully understood. Some reports point to an involvement of intrinsic pathways. In this context, the ability of Bcl-2 and Bcl-xL to protect against hypoxia-induced apoptosis has been demonstrated in a wide variety of cell lines in vitro and in vivo (Shimizu et al., 1995; Tsujimoto et al., 1997; Tamatani et al., 1998; Yoshimura et al., 1998) . Furthermore, the observation that chemical inhibition of caspase-9 blocks hypoxiainduced apoptosis points to a role of the apoptosome in hypoxia-induced apoptosis (Zhu et al., 2000; Malhotra et al., 2001) .
Other groups suggested that key elements of the death receptor pathway are mandatory for hypoxia-induced apoptosis. In this context, it has been reported that hypoxia can induce an upregulation of cell death receptors or death receptor ligands (Yaniv et al., 2002) , and that inhibition of caspase-8 or FADD may interfere with hypoxia-induced apoptosis under certain conditions (Malhotra et al., 2001; Chao et al., 2002) . To elucidate the relevant signaling pathways of hypoxiainduced apoptosis, we compared cells with genetically defined defects in either intrinsic or extrinsic signaling cascades with regard to their impact on apoptosis under hypoxic stress.
Results

Hypoxia induces apoptotic cell death, caspase activation and mitochondrial alterations in Jurkat T-lymphoma cells
To validate our model of hypoxic stress, we first analysed the onset of a distinct cellular response to biologically relevant hypoxia, the nuclear translocation of the transcription factor HIF-1a. As shown in Figure 1a , the hypoxia-inducible transcription factor HIF-1a could not be detected in nuclear extracts of Jurkat cells cultured under normoxic conditions. In contrast, HIF-1a translocation into the nucleus was found in Jurkat cells incubated under hypoxic conditions as determined by HIF-1a-binding to the HREconsensus sequences in an ELISA-based assay. In this assay, the competitive inhibition of DNA binding by specific oligonucleotides in nuclear lysates led to a complete abrogation of HIF-1a binding, whereas the addition of mutated oligonucleotides had no impact on DNA binding.
In order to precisely determine the apoptosis pathways triggered by hypoxia, several defined variants of Jurkat cells with defects of the death receptor (extrinsic) or mitochondrial (intrinsic) apoptosis pathway were used. In a first set of control experiments, the overexpression of Bcl-2 and the lack of FADD and caspase-8 were verified by Western blotting (Figure 1b) .
In a next array of experiments, apoptosis induction by application of hypoxic culturing conditions was tested in Jurkat cells. Exponentially growing cells were exposed for 24, 48 and 72 h to severe hypoxia (o0.1% O 2 ). As shown in Figure 2 , Jurkat cells were clearly susceptible to hypoxia-induced apoptosis. A small amount of Figure 1 Control of hypoxic conditions and expression of apoptosis signaling proteins in Jurkat cell clones. (a) Hypoxia leads to stabilization and nuclear translocation of HIF-1. Jurkat cells were incubated for 24 h under hypoxic and normoxic conditions. The HIF-1 concentration was determined in nuclear extracts of hypoxic or normoxic cells with or without preincubation with wild-type (wt) HIF-1 consensus oligonucleotides or mutated (mut) HIF-1 consensus oligonucleotides using an ELISA-based HIF-1 transcription factor assay. (b) Altered expression of apoptosis signaling proteins in genetically defined Jurkat cell clones and the respective control cells. Expression of apoptosis signaling proteins was tested in cytosolic extracts from untreated in Jurkat cell clones by Western Blot analysis using specific antibodies against caspase-8, FADD and Bcl-2. (Figure 2d ). After prolonged exposure to hypoxia, the rate of apoptotic cells further increased (Figure 2d ) amounting to 50-60% (48 h) and more than 90% (72 h), irrespective of the method for quantification of apoptosis (fluorescence microscopy of Hoechst 33342-stained cells or FACS analysis using light scatter characteristics).
Role of caspase-8 and FADD for hypoxia-induced apoptosis
Death receptor-mediated pathways involve the adaptor molecule FADD, which recruits procaspase-8 to the DISC to initiate the apoptotic signaling cascade (Muzio et al., 1998) . Proper death receptor signaling relies on both, the presence of procaspase-8 and the presence of the adaptor molecule FADD. Therefore, in the next set of experiments, hypoxia-induced apoptosis was determined in caspase-8-negative or FADD-negative Jurkat cells as well as the respective control cells (Jurkat A3).
Our results show that neither lack of caspase-8 nor lack of FADD had a significant impact on the susceptibility of the cells to undergo hypoxia-induced apoptosis (Figures 3 and 4) . After 48 h, the rate of apoptosis induction reached about 60% in caspase-8-negative cells (Figure 3e and f) and in FADD-negative cells (Figure 4e and f) and no significant differences in apoptosis induction were visible when caspase-8-or FADD-negative cells were compared with Jurkat A3 control cells. After 72 h of incubation in hypoxia, the majority of the cells were apoptotic in all three cell lines tested (Figures 3e and 4e) .
Caspases have been shown to function as central executioners of apoptotic cell death (Fischer et al., 2003) . To further substantiate our findings that hypoxiainduced apoptosis occurs independently of caspase-8 and FADD, caspase activation was analysed in caspase-8-and FADD-negative Jurkat cells and the respective control cells upon application of severe hypoxia. Our results show that incubation in hypoxia for 48 h led to the same extent of caspase activation in all three cell lines as determined by FACS-analysis upon staining of the cells with the CaspACE FITC-VAD-FMK in situ Marker (Figures 3b and 4b) . Furthermore, exposure to severe hypoxia also induced cleavage of the caspase-3 substrate PARP in FADD-negative and caspase-8-negative Jurkat cells as well as in Jurkat A3 control cells, while being absent under normoxic conditions (Figures 3 and 4d) .
To further corroborate the observation that the lack of caspase-8 and FADD has no influence on hypoxia-induced apoptosis, the activation of mitochondrial alterations was also tested. As shown in Figures 3c and 4c , application of hypoxia induced a breakdown of die mitochondrial membrane potential (Dc m ) in either cell line without differences in the extent of this mitochondrial alteration between Taken together, no difference in the kinetics and the extent of apoptosis induction could be found between caspase-8-negative, FADD-negative and control cells regarding different hallmarks of apoptosis induction pointing to caspase-8-and FADD-independent signaling pathways for hypoxia-induced apoptosis.
Role of mitochondrial death pathway for hypoxia induced-apoptosis
Since defined defects in receptor-mediated pathways did not reduce the sensitivity of the cells to hypoxia-induced apoptosis, other signaling pathways should be involved. Our experiments with the death receptor-deficient Jurkat cell clones revealed a hypoxia-induced breakdown of the mitochondrial membrane potential pointing to a possible role of the mitochondrial signaling pathway. Earlier investigations have shown that mitochondrial apoptosis signal transduction can be abrogated by overexpression of Bcl-2 or deficiency of caspase-9. To gain insight in the involvement of the intrinsic apoptotic pathway, Bcl-2-overexpressing Jurkat cells as well as Jurkat cells with expression of a dominant-negative caspase-9 mutant were tested in a next set of experiments.
Our results reveal that overexpression of Bcl-2 strongly interfered with hypoxia-induced apoptosis ( Figure 5 ). Bcl-2 significantly reduced the susceptibility of Jurkat cells to undergo hypoxia-induced apoptosis as determined by fluorescence microscopy ( Figure 5a and e) and light scatter characteristics (Figure 5f ). While after 48 h of exposure to severe hypoxia the rate of hypoxia-induced apoptosis amounted to more than 60% in Jurkat vector control cells, the Bcl-2-overexpressing cells almost completely failed to undergo apoptotic cell death (Figure 5a and e). Even when the hypoxic incubation period was extended to 72 h, the rate of the apoptosis induction remained below 20% in the Bcl-2-overexpressing cells, whereas more than 90% of the Jurkat vector control cells underwent apoptosis at the same time point (Figure 5e ).
To gain further insight into the importance of the mitochondria into the upstream signaling events of hypoxia-induced apoptosis, the influence of Bcl-2 overexpression on the onset of mitochondrial alterations and caspase activation was analysed. While vector control cells turned out to be rather sensitive to hypoxiainduced breakdown of the mitochondrial membrane potential, overexpression of Bcl-2 almost completely abrogated hypoxia-induced breakdown of Dc m ( Figure 5c ). Furthermore, Bcl-2 significantly inhibited hypoxia-induced caspase activation as determined by (Figure 5b ). This was further corroborated by the finding that cleavage of the caspase-3 substrate PARP by incubation in severe hypoxia as shown by the appearance of the 85 kDa cleaved PARP protein could only be observed in Jurkat vector control cells, while PARP cleavage was almost completely absent in Bcl-2-overexpressing cells (Figure 5d ). Under control conditions (normoxia), no intrinsic caspase activation, as shown by the absence of any PARP cleavage, could be found in Jurkat vector and Bcl-2-overexpressing cells.
Caspase-9 constitutes the initiator caspase in mitochondrial apoptosis pathways (Li et al., 1997; Stepczynska et al., 2001) . Therefore, the role of deficiency of caspase-9 for hypoxia-induced apoptosis was also investigated. Our results show that expression of dominant-negative caspase-9 mutant strongly interfered with hypoxia-induced apoptosis. Incubation of Jurkat cells expressing a dominant-negative caspase-9 mutant (Jurkat caspase-9 DN) under hypoxic conditions did not induce the morphological alterations typical for apoptotic cell death such as cell shrinkage as determined by FACS analysis using light scatter characteristics (Figure 6f ) or chromatin condensation and fragmentation as determined by fluorescence microscopy ( Figure  6a and e). After 48 h of incubation under severe hypoxia, the percentage of apoptotic cell death was significantly reduced in Jurkat caspase-9 DN when compared to vector control cells (Figure 6f ). Although the rate of apoptotic Jurkat caspase-9 DN cells slightly increased when the hypoxic incubation period was extended to 72 h, a considerable inhibitory effect of the caspase-9 DN mutant on apoptosis induction was still detectable.
Furthermore, activation of caspase-3 in response to hypoxic stress was significantly reduced in Jurkat caspase-9 DN cells compared to vector control cells as determined by FACS analysis after CaspAce s staining (Figure 6b ) and analysis of PARP cleavage (Figure 6d ). Again, under normoxic conditions, no cleavage of the caspase-3 substrate PARP could be detected in both, the Jurkat caspase-9 DN and the vector control cells. Incubation of vector control cells for 48 h in severe hypoxia induced a pronounced cleavage of PARP as indicated by a decrease in the full-length protein band (116 kDa) and the appearance of cleaved PARP (85 kDa). A small amount of cleaved PARP (85 kDa) was also found after incubation of Jurkat caspase-9 DN cells under hypoxic conditions. However, significant differences in the amount of PARP processing were clearly visible when compared to vector control cells, since a considerable higher amount of full-length PARP could still be detected in the caspase-9 DN cells (Figure 6d ).
In contrast, the dominant-negative caspase-9 mutant had almost no influence on the extent of the breakdown (Figure 6c ). Mitochondrial damage indicated by breakdown of DC m is followed by the release of cytochrome c into the cytosol as key event in the mitochondrial apoptotic cascade. To analyse the effect of Bcl-2 or DN caspase-9 on the mitochondria, the release of cytochrome c into the cytosol was determined by fluorescence microscopy ( Figure 7 ). When compared with the vector cells, hypoxia failed to induce release of cytochrome c from the mitochondrial intermembrane space of Bcl-2-overexpressing Jurkat cells (Figure 7) . In contrast, a partial cytochrome c release could be observed in caspase-9 DN cells. This is in accordance with the findings regarding the impact of Bcl-2 and DN caspase-9 on the mitochondrial membrane potential under hypoxic stress.
Thus, the dominant-negative mutant of caspase-9 abrogated hypoxia-induced caspase activation. In contrast, hypoxia-induced breakdown of the mitochondrial membrane potential and cytochrome c release was only partially influenced. Therefore, further experiments were performed to determine in how far the abrogation of caspase function is related to the inhibition of apoptosis solely or also protects against cell death per se.
To address this question, hypoxia-induced apoptosis in Bcl-2-overexpressing-, caspase-9 DN-and vector control Jurkat cells was directly compared with the rate of overall cell death determined by Trypan blue exclusion staining after incubation periods from 24 up to 96 h in hypoxia.
As shown in Figure 8 , apoptosis was the predominant mode of cell death in the vector controls. Over 50% of the vector control showed dye uptake as indication for cell death after 48 h in hypoxia and most of them exhibited a typical apoptotic morphology (Hoechst 33342 staining), while after 96 h, 499% of the vector control cells were dead and showed the typical morphology of apoptotic nuclear condensation as determined by Hoechst 33342 staining. In contrast, caspase-9 DN cells were more resistant against hypoxiainduced cell death with an overall cell death rate of 36% compared to 59% in vector controls after 48 h. It is of importance that over 50% of all DN caspase-9 cells died in a nonapoptotic manner (48 h: 55%; 72 h: 60%; 96 h: 53% of all Trypan blue-positive cells did not show apoptotic morphology). The Bcl-2-transfected Jurkat cells displayed an even more pronounced resistance against hypoxic stress. The rate of cell death was below 25% up to 72 h under hypoxia and most of those cells died in a nonapoptotic manner.
Although the rate of apoptosis did not differ significantly between Bcl-2 overexpressing and caspase-9 DN cells (48 h: 1674.5% apoptosis in caspase-9 DN cells; 14.672.9% apoptosis in Bcl-2 cells), the overall 
Discussion
In summary, our results clearly demonstrate that hypoxia-induced apoptosis follows the intrinsic, mitochondrial apoptosis pathway, while the extrinsic pathway is not involved. Neither the lack of caspase-8 nor the lack of FADD affected the time course or the rate of apoptosis in response to hypoxic conditions. In contrast, overexpression of Bcl-2 or expression of a dominantnegative caspase-9 mutant, both known to interfere with mitochondrial apoptosis signaling, significantly inhibited hypoxia-induced apoptosis. Thus, hypoxia-induced apoptosis is like most other forms of stress-induced apoptosis transmitted via mitochondrial death pathways. Several earlier reports suggested a key role of extrinsic or death receptor pathways for hypoxia-induced apoptosis. In this regard, hypoxia-induced upregulation of the cell death receptors CD95, CD95-ligand (CD95-L) or FADD have been described in neuronal cells, myocytes and endothelial cells (Felderhoff-Mueser et al., 2000; Mogi et al., 2001; Yaniv et al., 2002) . Although upregulation of cell death receptors or their ligands under hypoxic conditions may clearly occur, the upregulation per se is not indicative for a functional involvement of these molecules. Since FADD, CD95 and also CD95-L are all regulated by cellular stress, the upregulation may result from the normal stress response of the cell, rather than reflect an involvement in a certain apoptotic process. In this context, a similar effect has been documented for radiation-induced cell death: Although an upregulation of CD95 and CD95-L was observed, lack of FADD and caspase-8 did not interfere strongly with radiation-induced apoptosis (Belka et al., 1998 .
A similar argumentation applies to the fact that several authors observed the activation of both caspase-9 and caspase-8 following hypoxic stress in animal models of brain ischemia (Gibson et al., 2001; Khurana et al., 2002) . It is now clear that once the caspase network becomes fully activated, the processing of an individual caspase is not indicative for the upstream apoptosis signaling pathways Engels et al., 2000; Newton and Strasser, 2000; Wieder et al., 2001) . Thus, the finding that caspase-8 is activated during hypoxia-induced apoptosis may simply reflect a secondary activation of caspase-8 during the executional phase of apoptosis downstream of the mitochondria. Similar observations have been already made for radiation-and drug-induced apoptosis where caspase-8 acts during execution of apoptosis rather than during induction of programmed cell death (Belka et al., 1999a; Figure 6 Hypoxia-induced apoptosis is significantly reduced by expression of a dominant-negative caspase-9 mutant. Jurkat cells with expression of a dominant-negative caspase-9 mutant (C9dn) and the respective vector controls (Jurkat vector) were exposed for 48 h or the indicated times (e) to hypoxia. Induction of an apoptotic morphology was analysed by (a, e) fluorescence microscopy of Hoechst 33342-stained cell nuclei as well as by (f) FACS analysis using light scatter characteristics. Mechanisms of hypoxia-induced apoptosis M Weinmann et al Stepczynska et al., 2001) . Thus, only experiments using defined cell systems allow conclusions regarding the role of individual apoptosis modulators for hypoxia-induced cell death.
A single study suggested a functional importance of the death receptor pathway for hypoxia-induced apoptosis using a defined cell system. In this regard, the significance of FADD signaling has been analysed in a model of combined stress due to serum deprivation and hypoxia using FADD wild-type and dominant-negative cardiomyocytes (Chao et al., 2002) . The authors came to the conclusion that FADD is clearly involved in apoptosis induction by hypoxia. However, Chao et al. observed a similar degree of apoptosis under conditions of serum deprivation alone compared to hypoxia in combination with serum deprivation, but no induction of apoptosis under conditions of hypoxia alone. Thus, their results may be significant for apoptosis under conditions of serum deprivation, but not for the mechanisms of hypoxia-induced apoptosis per se.
To ensure that hypoxia alone and not a combination of hypoxia and reduced glucose supply triggers apoptosis, in our study, hypoxic cells and controls were kept in standard culture media (RPMI 1640) supplemented with glucose (190 mg/ml) and serum (10% fetal calf serum (FCS)). The glucose level in the culture media was monitored during the experiments. After 48 h, levels of glucose decreased down to 50% of the initial concentration. However significant differences in glucose levels between hypoxic or normoxic cultures could not be observed during the first 48 h. After longer incubation periods, the concentration of glucose in normoxic cultures was even lower than in hypoxic cultures, which may be due to growth arrest and cell death under hypoxia.
Under these conditions, we could clearly demonstrate that hypoxia-induced apoptosis relies almost exclusively on the intrinsic pathway, whereas the extrinsic pathway had no significant impact. Both, the protection of the mitochondrial membrane potential by Bcl-2 and the Figure 7 Hypoxia-induced cytochrome c release is abrogated by over expression of Bcl-2, but not by expression of a dominantnegative caspase-9 mutant. Jurkat cells with expression of Bcl-2 (Bcl-2), a dominant-negative caspase-9 mutant (C9dn) and the respective vector controls (Jurkat vector) were exposed for 48 h to hypoxia or normoxia. Release of cytochrome c from the mitochondrial intermembrane space was analysed by fluorescence microscopy. The lower panel (fluorescence image) shows cytochrome c staining by fluorescence microscopy. The granular staining pattern on the green background indicates cytocrome c staining mostly restricted to the intact mitochondria in normoxic controls and in Bcl-2-transfected cells under hypoxic and normoxic conditions, whereas the lowering of the intensity and the homogeneous distribution of staining all over the cell demonstrates the release of cytochrome c into the cytoplasma under hypoxia in vector controls and slightly less pronounced in C9dn cells. In the upper panel, unspecific fluorescence/blurring was removed by nearest neighbor deconvolution. The deconvolution technique subtracts the unspecific background and generates a picture showing the cytochrome c stain restricted to intact mitochondria. These pictures show the release of cytochrome c from the intermembrane space under hypoxia in C9dn cells and vector controls, whereas Bcl-2 protects completely against cytocrome c relase under hypoxia. Note that overexpression of Bcl-2 causes an inrease in size of mitochondria as shown by (Kowaltowski et al. (2002) Mechanisms of hypoxia-induced apoptosis M Weinmann et al inhibition of the proper formation of the apoptosome downstream of the mitochondria by expression of a dominant-negative caspase-9 mutant resulted in increased resistance against hypoxia-induced apoptosis. The requirement of caspase 9 for proper execution of hypoxia-induced apoptosis was most obvious during the initial phase up to 48 h. Vector controls exhibited almost 60% of cell death mainly due to apoptosis after this period, whereas the apoptotic rate in caspase-9 DN cells remained below 20%. Other forms of cell death after longer incubation periods were partly inhibited by lack of proper caspase-9 function. In keeping with our data earlier reports described protective effects of Bcl-2 and Bcl-xL against hypoxiainduced apoptosis (Shimizu et al., 1995; Banasiak et al., 1999) , and showed that chemical inhibition of caspase-9 protects against hypoxia (Zhu et al., 2000; Alarcon et al., 2001; Malhotra et al., 2001) .
Despite the fact that hypoxia-induced apoptosis requires Bcl-2 inhabitable steps and activation of caspase-9, a different picture emerges when hypoxiainduced cell death is analysed. Our data show clearly that overexpression of Bcl-2 not only protects against caspase activation and apoptosis but also against cell death as indicated by breakdown of the mitochondrial membrane potential. In contrast, the dominant-negative mutant of caspase-9 only interfered with hypoxiainduced caspase activation but only partially with hypoxia-induced cell death. Thus, abrogation of caspase function only protects against the proper execution of programmed cell death but not against cell death per se. In this regard, it is likely that caspase-9 is required for apoptosis induction per se but is also involved in the propagation of mitochondrial damage. It has been shown that caspases are involved in the release of SMAC/diablo from the mitochondria (Lopez-Hernandez et al., 2003), which in turn may neutralize inhibitory IAPs (Verhagen et al., 2000) and promote cell death.
Compared with the effects of caspase-9 inhibition, Bcl-2 exerts an almost complete protection against cell death. The increase of cell death in Bcl-2-overexpressing cells after very long incubation periods of 96 h probably reflects the complete breakdown of the energy supply of the cell. This assumption is supported by the fact that Figure 8 Expression of a dominant-negative caspase-9 mutant reduces mainly hypoxia-induced apoptosis, whereas overexpression of Bcl-2 reduces both apoptotic and nonapoptotic cell death. Jurkat cells with overexpression of Bcl-2, expression of a dominant-negative caspase-9 mutant (C9dn) and the respective vector controls (Jurkat vector) were exposed for 24 h up to 96 h to hypoxia. Induction of an apoptotic morphology was analysed by fluorescence microscopy of Hoechst 33342-stained cell nuclei, whereas overall cell death was evaluated by counting of cells after Trypan blue exclusion stain. Upper panel: Time kinetics (24-96 h) of cell death (Trypan blue exclusion stain) and apoptosis (Hoechst stain) in dominant-negative caspase-9 mutant cells (C9dn), cells with overexpression of Bcl-2 (Bcl-2) compared to vector controls. Middle panel: Cell death (Trypan blue exclusion stain) in dominant-negative caspase-9 mutant cells, cells with overexpression of Bcl-2 compared to vector controls after 72 h in hypoxia. Lower panel: Apoptosis analysed by fluorescence microscopy of Hoechst 33342-stained cell nuclei in dominant-negative caspase-9 mutant cells, cells with overexpression of Bcl-2 compared to vector controls after 72 h in hypoxia Mechanisms of hypoxia-induced apoptosis M Weinmann et al almost no glucose is detectable in culture medium after 96 h in hypoxia.
The observation of a general protective effect of Bcl-2 is in keeping with the observation of several other groups using hypoxia and also own data on immediate radiation-induced cell death. In this regard, Steinbach et al. (2003) demonstrated in glioma cells that Bcl-x L protects against hypoxia-induced cell death. In case of radiation-induced apoptosis, the inhibition of the caspase cascade shifted apoptotic cell death to necrotic cell death. Bcl-2 however, interfered strongly with early forms of necrotic cell death (Rudner et al., 2001a) . Similarly, the depletion of ATP that interferes with proper apoptosome formation triggers a shift from apoptosis to necrosis in case of drug-induced apoptosis (Ferrari et al., 1998) . Taken together, it seems very likely that the integrity of the mitochondria is the key decision point for hypoxia-induced cell death.
A paradigm of the mitochondrial pathway is the p53-mediated apoptosis signaling cascade, which is initiated by genotoxic stress leading to mitochondrial damage and release of cytochrome c via activation of proapoptotic Bcl-2 family members including Bax, Bak, Puma and Noxa (Oda et al., 2000; Cheng et al., 2001; Wei et al., 2001) . The relevance of p53 for hypoxia-induced apoptosis is not fully elucidated and may be cell-type specific. Hypoxia-induced p53-dependend apoptosis is well established in various cell systems (Graeber et al., 1996; Banasiak and Haddad, 1998) , although also p53-independend forms of hypoxia-induced apoptosis have been observed (Bialik et al., 1997) .
It has been speculated that hypoxic activation of HIF-1 may have functional significance for p53-dependend apoptosis under hypoxia. Two distinguishable forms of HIF-1a, phosphorylated and dephosphorylated, were induced during severe hypoxia. Phosphorylated HIF-1a is the major form that promotes gene induction by heterodimerization with HIF-1b, whereas the dephosphorylated HIF-1a is the form that can mediate apoptosis by binding to and stabilizing p53 (Suzuki et al., 2001) . Vice versa, p53 can interfere with HIF-1 function. It has been described that p53 is able to repress HIF-1-stimulated transcription under hypoxia, although this may be only relevant under conditions of very severe hypoxia (Blagosklonny et al., 1998) .
We observed the induction of HIF-1 under hypoxic conditions in our experimental system, but a relation to apoptosis via interaction with p53 cannot be postulated, because all Jurkat cells are know to be p53 negative (Park et al., 2002) . Therefore, the activation of mitochondrial apoptotic pathways under hypoxia occurs independently of p53 in this setting.
The knowledge about the relevant signaling cascades for hypoxia-induced apoptosis can provide important insights in the mechanisms of acquired apoptotic deficiencies during malignant progression in poorly oxygenated tumors. It is well established that poor oxygenation of solid tumors is associated with poor prognosis. This may not only be due to direct effects of hypoxia on the efficacy on certain tumor treatment modalities but also due to the evolvement of resistant tumor cells during the ontogenesis of a tumor under hypoxic conditions. The irregular vasculature of solid tumors creates regions of chronic hypoxia and regions of transient hypoxia, which are characterized by periods of hypoxia and reoxygenation. Even cells in the close proximity of blood vessels can be subjected to periods of hypoxia followed by reoxygenation.
It has been shown that in vitro modelling of this in vivo situation by repeated exposure to conditions of severe hypoxia induces apoptosis and selects for cells with defects in relevant apoptotic pathways (Graeber et al., 1996; Kim et al., 1997) . Our observations regarding the significance of the intrinsic pathway for hypoxiainduced apoptosis suggest that a selection pressure may be mainly exerted on elements of this signaling cascade. If extrinsic pathways are not involved in hypoxia-induced apoptosis, the cells may escape this type of selection pressure and therefore retain functional extrinsic apoptotic pathways in a hypoxic microenvironment. Thus, extrinsic pathways of apoptosis may represent a therapeutic target in hypoxic tumors, which are resistant to stimuli of the mitochondrial signaling cascade.
Materials and methods
All biochemicals were obtained from Sigma chemicals (Deisenhofen, Germany) unless otherwise specified. Hoechst 33342 was purchased from Calbiochem. The proton shuttle carbonylcyanide-m-chlorphenylhydrazone (CCCP) was purchased from Sigma and dissolved in DMSO.
Cells and culture conditions
Jurkat T-lymphoma cells were obtained from ATCC (Bethesda, MD, USA). Caspase-8-and FADD-negative Jurkat cells as well as the Bcl-2-overexpressing Jurkat cells and the respective vector control cells were used as already described (Belka et al., 1999a Rudner et al., 2001a, b; Jendrossek et al., 2003a) . The expression vector for the T7-tagged caspase-9 DN mutant was a kind gift from E Alnemri (Philadelphia, PA, USA). Caspase-9 DN-expressing Jurkat cells were prepared as already described .
For all experiments, cells were grown in RPMI 1640 medium supplemented with 10% FCS and glucose (190 mg/ml) (Gibco Life Technologies, Eggenstein, Germany) and maintained in a humidified incubator at 371C and 5% CO 2 .
For incubation under hypoxic conditions, cells were placed into hypoxic chambers (GasPak 100, Becton Dickinson, Heidelberg, Germany). The hypoxic period commenced (t 0 ¼ 0 h) when the chamber was sealed. Severe hypoxic conditions (o0.1% O 2 ) were reached after 60 min as indicated by a methylen blue indicator inserted into the system (Becton Dickinson, Heidelberg, Germany). To ensure exponential growth for all experiments, 100 000 cells/ml were seeded at t 0 .
HIF-1 activation
Nuclear extracts were obtained using a nuclear extract kit (Active Motif, Rixensart, Belgium). Cells (8 Â 10 6 ) were washed in ice-cold PBS (pH 7.5) containing a phosphatase inhibitor buffer (PIB) (125 mM NaF, 250 mM b-glycerophosphate, 250 mM para-nitrophenyl phosphate (PNPP), 25 mM NaVO 3 ), scraped from the plate and washed again in PBS 1 Â /PIB. Cell pellets were resuspended in 1 ml ice-cold hypotonic buffer (20 mM HEPES pH 7.5, 5 mM NaF, 10 mM Na 2 MoO 4 , 0.1 mM EDTA) and incubated for 15 min. Nonidet P-40 (10%) was added to a final concentration of 0.5% (v/v) detergent. The homogenate was centrifuged for 30 s at 41C 13 000g. The supernatant was discarded and the nuclear pellet resuspended in 50 ml lysis buffer (20 mM HEPES, pH 7.5, 400 mM NaCl, 20% glycerol, 0.1 mM EDTA, 10 mM NaF, 10 mM Na 2 MoO 4 , 1mM NaVO 3 , 10mM PNPP, 10 mM bglycerophosphate, 0.1 M dithiothreitol (DTT), 1% protease inhibitor cocktail) and incubated for 30 min at 41C on a rocking platform. Debris was separated by centrifugation at 14 000g for 10 min at 41C and the supernatants were stored at À801C. HIF-1 activation was detected and quantified using an ELISA-based HIF-1 transcription factor assay (Active Motif, Rixensart, Belgium) according to the manufacturer's recommendations. In brief, protein content in nuclear cell extracts was determined by a DC protein assay (BioRad, Munich, Germany) and adjusted to 2 mg/ml for the assay. Samples were added to a 96-well microtiter plate covered with oligonucleotides (5 0 -TACGTGCT-3 0 ) representing a hypoxia-responsive element (HRE) from the erythropoietin gene as binding motif for HIF-1. Nuclear cell extracts from Cos-7 cells treated with CoCl 2 were used as positive controls. Additionally, samples were incubated with 20 pmol/well wtHIF-1 consensus oligonucleotides (5 0 -GATCGCCCTACGTGCTGTCTCAGATC-3 0 ) or mutated HIF-1 consensus oligonucleotides (5 0 -GATCGCCC-TAAAAGCTGTCTCAGATC-3 0 ) (both dsDNA) for HIF-1 as a competitor for HIF-1 binding to the plate in order to monitor the specifity of the assay. With a concentration of 20 pmol/well, the wtHIF-1oligonucleotide prevented HIF-1 binding completely, while mutHIF-1 oligonucleotides had no effect on binding. Mouse anti HIF-1 antibody was added as primary antibody (1 : 1000) and detected with anti-mouse HRP-conjugated IgG (1 : 1000) (both from Active Motif, Rixensart, Belgium). Developing solution was added and HIF-1 binding was quantified after 12 min by spectrophotometric analysis at 450 vs 620 nm (Anthos 2010 plate reader, Anthos, Krefeld, Germany). The values are expressed OD at 450 vs 620 nm (means71 s.d.).
Determination of cell death and apoptosis
Cell death was quantified by Trypan blue exclusion stain and FACS using light scatter characteristics after 24 h, 48 h, 72 h and 96 h of incubation in hypoxic or normoxic conditions. In parallel, apoptosis was quantified after 48 h using the CaspAce s detection system (Promega, Mannhein, Germany), which allows in vivo staining of active caspases. The CaspAce s staining was performed according to the manufacturer's guidelines. All flow cytometric experiments were performed employing a FACS Calibur flow cytometer (Becton Dickinson, Heidelberg, Germany). Furthermore, apoptosis was also quantified after staining of the cells with Hoechst 33342 and subsequent fluorescence microscopy. In brief, cells were incubated with Hoechst 33342 at a final concentration of 1.5 mM for 15 min. Cell morphology was then determined by fluorescence microscopy (Zeiss Axiovert 135, Carl Zeiss, Jena, Germany) using an excitation wavelength filter of 380 nm. A minimum of 250 cells was counted and cells with intense chromatin clumping were considered as apoptotic.
Determination of the mitochondrial membrane potential
The mitochondrial transmembrane potential (DC m ) was analysed using the DC m specific stain TMRE (Molecular probes, Mobitech, Go¨ttingen Germany). In brief, at the indicated time points, 10 5 cells were stained in a solution containing 25 nM TMRE for 30 min. Staining was quantified by FL2 and scatter characteristics employing a FACS Calibur flow cytometer (Becton Dickinson, Heidelberg, Germany).
Immunoblotting
Cells (1 Â 10 5 ) were lysed in a lysis buffer containing 25 mM HEPES, 0.1%. SDS, 0.5% deoxycholate, 1% Triton X-100, 10 mM EDTA, 10 mM NaF and 125 mM NaCl. After removing insoluble material by centrifugation for 10 min at 13 000 r.p.m., 20 mg lysate was diluted in sample buffer and separated by SDS-PAGE. Blotting was performed employing a tank blotting apparatus (Biorad, Munich, Germany) onto Hybond C membranes (Amersham, Braunschweig, Germany). Equal protein loading was confirmed by Ponceau S staining (Sigma). Blots were blocked in TBS buffer containing 0.05% Tween 20 and 5% FCS at room temperature for 15 min. Caspase-9, caspase-3 and PARP were detected using cleavage-specific antibodies from Cell Signaling (Frankfurt, Germany). Caspase-8 was detected using a mouse monoclonal antibody directed against the p18 as described previously and was obtained from BioCheck (Mu¨nster). Bcl-2 expression was tested using an Bcl-2 antibody (Santa-Cruz, Heidelberg, Germany). After repeated washings with TBS/ Tween 20 (0.05%), the membrane was incubated with the secondary antibody (alkaline phosphatase coupled anti-IgG 1 : 20.000, Santa-Cruz-Biotech, Heidelberg, Germany) in TBS/ Tween for 3 h at room temperature and washed three times with TBS/Tween. The detection of antibody binding was performed by enhanced chemoluminescence.
Determination of mitochondrial cytochrome c release
The release of cytochrome c from the mitochondria was determined by fluorescence microcopy using an Zeiss Axiovert 200 microscope. In brief, cells were immobilized on coverslips with 0.1% poly-L-lysine, fixed with 2.5% formaldehyde in PBS and permeabilized with 0.1% Triton X-100 in PBS. After blocking with 10% FCS, cells were stained with the anticytochrome c primary antibody (Becton & Dickinson/Pharmingen, Heidelberg, Germany) for 1 h at room temperature. Cells were washed several times and incubated with the secondary antibody (Alexa Fluort488-conjugated anti-mouse antibody, Molecular Probes, Mobitech, Go¨ttingen, Germany) for 45 min. Finally, the coverslips were mounted with Mowiol (Sigma, Deisenhofen, Germany). Cells were analysed with Â 1000 magnification and documented using an CCD camera device (Photometrix SensysCam). Green fluorescence was documented using filter set 09 (BP450-490/FT510/LP515, Zeiss, Germany). Unspecific fluorescence/blurring was removed by nearest neighbor deconvolution (MetaMorph s , Visitron Systems GmbH, Germany) using the following settings: Filtersize: 20, xy spacing: 2.0, z spacing: 0.5, deconvolution wavelength: 540 nm, noise suppression on. Raw-tiffs were background reduced before processing.
